457 related articles for article (PubMed ID: 27493107)
21. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis A and hepatitis B infection prevalence and associated risk factors in men who have sex with men, Bangkok, 2006-2008.
Linkins RW; Chonwattana W; Holtz TH; Wasinrapee P; Chaikummao S; Varangrat A; Tongtoyai J; Mock PA; Curlin ME; Sirivongrangson P; van Griensven F; McNicholl JM
J Med Virol; 2013 Sep; 85(9):1499-505. PubMed ID: 23797893
[TBL] [Abstract][Full Text] [Related]
23. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of hepatitis A, B and C serological markers in children from western Mexico.
Escobedo-Meléndez G; Fierro NA; Roman S; Maldonado-González M; Zepeda-Carrillo E; Panduro A
Ann Hepatol; 2012; 11(2):194-201. PubMed ID: 22345336
[TBL] [Abstract][Full Text] [Related]
25. Serologic markers of hepatitis B and A infections in the healthy population.
Sabău M; Kiss E; Muntean I; Căpîlnă E
Virologie; 1983; 34(3):197-201. PubMed ID: 6636535
[TBL] [Abstract][Full Text] [Related]
26. A ten year serological survey of hepatitis A, B and C viruses infections in Nepal.
Sawayama Y; Hayashi J; Ariyama I; Furusyo N; Kawasaki T; Kawasaki M; Itoh K; Acharya GP; Kashiwagi S
J Epidemiol; 1999 Nov; 9(5):350-4. PubMed ID: 10616269
[TBL] [Abstract][Full Text] [Related]
27. Viral hepatitis prevalence in patients with active and latent tuberculosis.
Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community.
Chapman BA; Burt MJ; Frampton CM; Collett JA; Yeo KH; Wilkinson ID; Cook HB; Barclay MJ; Ross AG; George PM
N Z Med J; 2000 Sep; 113(1118):394-6. PubMed ID: 11062814
[TBL] [Abstract][Full Text] [Related]
29. [Markers of hepatitis B, C and HIV among orthopedic patients and staff at a Polish university hospital].
Gańczak M; Bohatyrewicz A; Szych Z; Białecki P
Chir Narzadow Ruchu Ortop Pol; 2008; 73(2):83-8. PubMed ID: 18846999
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
[TBL] [Abstract][Full Text] [Related]
32. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
33. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of Hepatitis A, B and C Among a Sample of Refugees in Egypt: An Exploratory Survey.
El-Ghitany EM; Ashour A; Fekry MM; Elrewany E; Farghaly AG; Omran EA
J Epidemiol Glob Health; 2022 Dec; 12(4):430-440. PubMed ID: 36107333
[TBL] [Abstract][Full Text] [Related]
35. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
Kramer JR; Hachem CY; Kanwal F; Mei M; El-Serag HB
Hepatology; 2011 Jan; 53(1):42-52. PubMed ID: 21254161
[TBL] [Abstract][Full Text] [Related]
36. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
Vargas JI; Jensen D; Sarmiento V; Peirano F; Acuña P; Fuster F; Soto S; Ahumada R; Huilcaman M; Bruna M; Jensen W; Fuster F
J Med Virol; 2016 Apr; 88(4):639-46. PubMed ID: 26381185
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study.
Pinto FP; Ferreira OC; Olmedo DB; Precioso PM; Barquette FR; Castilho MC; Silva SG; Pôrto LC
Ann Hepatol; 2015; 14(6):815-25. PubMed ID: 26436353
[TBL] [Abstract][Full Text] [Related]
38. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
39. Antibodies against HBV, HCV and HAV detected by using microparticle enzyme immunoassay in hepatitis outpatients.
Boboş C; Spânu I; Bîlc AM
Roum Arch Microbiol Immunol; 2006; 65(3-4):87-92. PubMed ID: 18389722
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
Seo DH; Whang DH; Song EY; Kim HS; Park Q
Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
